1. Home
  2. BNR

as of 03-10-2026 11:48am EST

$22.81
$0.66
-2.81%
Stocks Health Care Medical Specialities Nasdaq

Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.

Founded: 2014 Country:
China
China
Employees: 674 City: N/A
Market Cap: 252.7M IPO Year: 2019
Target Price: N/A AVG Volume (30 days): 13.1K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: N/A EPS Growth: N/A
52 Week Low/High: $2.18 - $41.72 Next Earning Date: N/A
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): 136.32% Revenue Growth (next year): -6.32%
P/E Ratio: N/A Index: N/A
Free Cash Flow: N/A FCF Growth: N/A

Share on Social Networks: